Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1988 1
1990 1
1997 1
2002 1
2005 1
2006 1
2007 3
2008 2
2009 2
2012 2
2013 4
2014 5
2015 5
2016 6
2017 6
2018 13
2019 9
2020 15
2021 10
2022 22
2023 18
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Results by year

Filters applied: . Clear all
The following terms were ignored: %, %, %, %
The following terms were not found in PubMed: 22Virus, 5BMeSH
Page 1
Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
Andre T, Amonkar M, Norquist JM, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt CJA, Smith D, Garcia-Carbonero R, Sevilla I, De La Fouchardiere C, Rivera F, Elez E, Diaz LA Jr, Yoshino T, Van Cutsem E, Yang P, Farooqui M, Le DT. Andre T, et al. Lancet Oncol. 2021 May;22(5):665-677. doi: 10.1016/S1470-2045(21)00064-4. Epub 2021 Apr 1. Lancet Oncol. 2021. PMID: 33812497 Clinical Trial.
Eligible patients were randomly assigned (1:1) centrally by use of interactive voice response or integrated web response technology to receive pembrolizumab 200 mg intravenously every 3 weeks or investigator's choice chemotherapy (mFOLFOX6 [leucovorin, fluorouracil, and ox …
Eligible patients were randomly assigned (1:1) centrally by use of interactive voice response or integrated web response technology t …
Patient-reported outcomes in capmatinib-treated patients with METex14-mutated advanced NSCLC: Results from the GEOMETRY mono-1 study.
Wolf J, Garon EB, Groen HJM, Tan DSW, Gilloteau I, Le Mouhaer S, Hampe M, Cai C, Chassot-Agostinho A, Reynolds M, Sherif B, Heist RS. Wolf J, et al. Eur J Cancer. 2023 Apr;183:98-108. doi: 10.1016/j.ejca.2022.10.030. Epub 2022 Dec 10. Eur J Cancer. 2023. PMID: 36822130
PROs were collected at baseline and every six weeks thereafter using EORTC QLQ-C30 global health status/quality of life (GHS/QoL), QLQ-LC13 symptoms, and EQ-5D-5L visual analogue scale (VAS) questionnaires. RESULTS: As of 6 January 2020, 27/28 1L and 65/69 2L(+) patients h …
PROs were collected at baseline and every six weeks thereafter using EORTC QLQ-C30 global health status/quality of life (GHS/QoL), QLQ-LC13 …
Temporal properties of positive and negative defocus on emmetropization.
Zhu X, Kang P, Troilo D, Benavente-Perez A. Zhu X, et al. Sci Rep. 2022 Mar 4;12(1):3582. doi: 10.1038/s41598-022-07621-6. Sci Rep. 2022. PMID: 35246571 Free PMC article.
A total of forty-six marmosets were treated monocularly with soft contact lenses for 4 weeks from 10 weeks of age (OD: + 5D or - 5D; OS: plano). Two control groups wore + 5D (n = 5) or - 5D (n = 13) lenses continuously for 9 h/day. ...Interrupting defo …
A total of forty-six marmosets were treated monocularly with soft contact lenses for 4 weeks from 10 weeks of age (OD: + 5D or - 5 …
Systematic review and meta-analysis on the association between chronic low back pain and cognitive function.
Pereira Nery ECH, Rocha NP, Cruz VT, Silva AG. Pereira Nery ECH, et al. Pain Pract. 2023 Apr;23(4):399-408. doi: 10.1111/papr.13194. Epub 2022 Dec 25. Pain Pract. 2023. PMID: 36504248 Review.
Low to very low-quality evidence suggests impaired cognitive function in individuals with LBP compared to asymptomatic controls for problem solving (k = 5; d = 0.33; CI = 0.16-0.50; z = 3.85 p = 0.0001), speed of information processing (k = 5; d = 0.44; CI = 0.22-0.65; z = …
Low to very low-quality evidence suggests impaired cognitive function in individuals with LBP compared to asymptomatic controls for problem …
Thickness-Dependent Superconductivity in a Layered Electride on Silicon.
Averyanov DV, Sokolov IS, Parfenov OE, Taldenkov AN, Karateev IA, Kondratev OA, Tokmachev AM, Storchak VG. Averyanov DV, et al. Small. 2023 Sep;19(39):e2302065. doi: 10.1002/smll.202302065. Epub 2023 May 31. Small. 2023. PMID: 37259278
The challenge is to make the materials into epitaxial films, preferably integrated with mature technological platforms to facilitate their potential applications. ...
The challenge is to make the materials into epitaxial films, preferably integrated with mature technological platforms to facilitate …
State of the Art of BIM Integration with Sensing Technologies in Construction Progress Monitoring.
ElQasaby AR, Alqahtani FK, Alheyf M. ElQasaby AR, et al. Sensors (Basel). 2022 May 4;22(9):3497. doi: 10.3390/s22093497. Sensors (Basel). 2022. PMID: 35591189 Free PMC article. Review.
The qualitative analysis showed a shortage of articles performed on 5D assessment. Then, statistical analysis is conducted using a meta-analytic regression model to determine the development of the performance of object recognition indicators. ...Finally, this is the first …
The qualitative analysis showed a shortage of articles performed on 5D assessment. Then, statistical analysis is conducted using a me …
A review of patient-reported outcomes used for regulatory approval of oncology medicinal products in the European Union between 2017 and 2020.
Teixeira MM, Borges FC, Ferreira PS, Rocha J, Sepodes B, Torre C. Teixeira MM, et al. Front Med (Lausanne). 2022 Aug 12;9:968272. doi: 10.3389/fmed.2022.968272. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36035431 Free PMC article. Review.
Nevertheless, PROM selected relied on the EORTC (41.3%), FACIT (17.1%) and EQ-5D (29.2%) measures. A total of 76 indications (59.4%) had PRO reviewers comments included in the EPAR, however only 22 indications (17.8%) included label claims in the SmPC. ...
Nevertheless, PROM selected relied on the EORTC (41.3%), FACIT (17.1%) and EQ-5D (29.2%) measures. A total of 76 indications (59.4%) …
A systematic review of health state utility values in Thai cancer patients.
Kangwanrattanakul K. Kangwanrattanakul K. Expert Rev Pharmacoecon Outcomes Res. 2022 Dec;22(8):1171-1186. doi: 10.1080/14737167.2022.2123796. Epub 2022 Sep 26. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 36084926
The EQ-5D 3 Level Version was commonly used to identify the HSUVs of Thai patients with cancer. Meanwhile, the use of the EQ-5D 5 Level Version was supported by psychometric testing. However, mapping techniques between disease-specific and health preference-based in …
The EQ-5D 3 Level Version was commonly used to identify the HSUVs of Thai patients with cancer. Meanwhile, the use of the EQ-5D …
First trans-diagnostic experiences with a novel micro-choice based concentrated group rehabilitation for patients with low back pain, long COVID, and type 2 diabetes: a pilot study.
Kvale G, Søfteland E, Jürgensen M, Wilhelmsen-Langeland A, Haugstvedt A, Hystad SW, Ødegaard-Olsen ØT, Aarli BB, Rykken S, Frisk B. Kvale G, et al. BMC Med. 2024 Jan 11;22(1):12. doi: 10.1186/s12916-023-03237-3. BMC Med. 2024. PMID: 38200486 Free PMC article. Clinical Trial.
Client Satisfaction Questionnaire (CSQ-8)) (1 week), Work and Social Adjustment Scale (WSAS), Brief Illness Perception Questionnaire (BIPQ), and self-rated health status (EQ-5D-5L) were registered at baseline and 3-month follow-up. RESULTS: Of the 241 included participants …
Client Satisfaction Questionnaire (CSQ-8)) (1 week), Work and Social Adjustment Scale (WSAS), Brief Illness Perception Questionnaire (BIPQ), …
Serum alarm antiproteases in systemic sclerosis patients.
Olewicz-Gawlik A, Trzybulska D, Graniczna K, Kuznar-Kaminska B, Katulska K, Batura-Gabryel H, Frydrychowicz M, Danczak-Pazdrowska A, Mozer-Lisewska I. Olewicz-Gawlik A, et al. Hum Immunol. 2017 Sep;78(9):559-564. doi: 10.1016/j.humimm.2017.06.002. Epub 2017 Jun 9. Hum Immunol. 2017. PMID: 28606626
Alarm antiproteases, i.e. secretory leukocyte protease inhibitor ad elafin, are key mediators in innate immune response and integrate innate and adaptive immunity systems. The aim of the study was to assess clinical significance of serum levels of alarm antiproteases, elaf …
Alarm antiproteases, i.e. secretory leukocyte protease inhibitor ad elafin, are key mediators in innate immune response and integrate …
125 results